Trials / Unknown
UnknownNCT03106259
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj
Observational Study to Evaluate the Safety of FURESTEM-RA Inj. in Moderate to Severe Rheumatoid Arthritis Patients Who Participated in Phase 1 Clinical Trial of FURESTEM-RA Inj
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Observational Study to evaluate the safety of FURESTEM-RA lnj. in moderate to severe rheumatoid arthritis patients who participated in phase 1 clinical trial of FURESTEM-RA lnj.
Detailed description
This is a observational study, single center, open label, study of safety of FURESTEM-RA Inj. in subjects with moderate to severe rheumatoid arthritis. Subjects participating in this observational study originally participated in study FURESTEM-RA Inj. \[NCT02221258\]
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FURESTEM-RA Inj. | Non-interventional observational study |
Timeline
- Start date
- 2016-06-29
- Primary completion
- 2017-01-24
- Completion
- 2021-03-21
- First posted
- 2017-04-10
- Last updated
- 2018-02-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03106259. Inclusion in this directory is not an endorsement.